Welcome to the International Dermatology Outcome Measures
International Dermatology Outcome Measures is a non-profit organization seeking to develop and validate measures throughout dermatology with an initial focus on psoriatic disease. IDEOM strives for the establishment of patient-centric outcomes to enhance the research and treatment of dermatological conditions. Launched in 2013, IDEOM seeks to bring together physicians, researchers, government agencies, pharmaceutical companies, payers and patients from around the globe to develop and validate measures throughout the field of dermatology with an initial focus on psoriasis.
The group’s inaugural meeting in Boston established a need for consistent core measurements when evaluating clinical trials and therapeutic effectiveness. At the second meeting in Toronto, the group began discussing what elements are critical to be measured in psoriatic clinical trials and in clinical practice. The third meeting focused on what patients and European regulators were interested in seeing in measures.
Save the Dates…
The 2018 IDEOM Annual Meeting will be held in Washington, DC on May 4-5, 2018. Details coming soon.
In the News…
Accepted poster presentation at the Society of Investigative Dermatology: “Identifying a core domain set to assess psoriasis in clinical trials: Delphi survey of patients and healthcare professionals from the International Dermatology Outcome Measures Psoriasis Initiative”.